| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 461,055 | 427,183 | 400,933 | 447,965 | | Cost of Revenue | 200,544 | 185,222 | 172,031 | 201,289 | | | Gross Profit | 260,511 | 241,961 | 228,902 | 246,676 | | | Operating Expenses | | Research Development | 39,517 | 42,406 | 37,152 | 41,120 | | Selling General and Administrative | 153,623 | 143,670 | 140,313 | 154,497 | | Non Recurring |
-
|
-
|
-
| 28,757 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 67,371 | 55,885 | 51,437 | 22,302 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,664) | 3,756 | (385) | (10,258) | | Earnings Before Interest And Taxes | 65,707 | 59,641 | 51,052 | 12,044 | | Interest Expense | 14,487 | 10,367 | 7,807 | 7,985 | | Income Before Tax | 51,220 | 49,274 | 43,245 | 4,059 | | Income Tax Expense | 11,920 | 9,974 | 11,202 | 10,567 | | Minority Interest | (776) | (3,109) |
-
| (1,708) | | | | Net Income From Continuing Ops | 38,524 | 36,191 | 32,043 | (8,216) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 38,524 | 36,191 | 32,043 | (8,216) | | Preferred Stock And Other Adjustments |
-
| 1,778 | (1,778) |
-
| | | Net Income Applicable To Common Shares | $38,524 | $37,969 | $30,265 | ($8,216) |
|
1.00% Nasdaq 0.00%
Income Statement
